GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gwo Xi Stem Cell Applied Technology Co (ROCO:6704) » Definitions » YoY EBITDA Growth

Gwo Xi Stem Cell Applied Technology Co (ROCO:6704) YoY EBITDA Growth : 100.44% (As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Gwo Xi Stem Cell Applied Technology Co YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Gwo Xi Stem Cell Applied Technology Co's YoY EBITDA Growth for the quarter that ended in Dec. 2024 was 100.44%.

Gwo Xi Stem Cell Applied Technology Co's EBITDA per Share for the six months ended in Dec. 2024 was NT$0.00.


Gwo Xi Stem Cell Applied Technology Co YoY EBITDA Growth Historical Data

The historical data trend for Gwo Xi Stem Cell Applied Technology Co's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gwo Xi Stem Cell Applied Technology Co YoY EBITDA Growth Chart

Gwo Xi Stem Cell Applied Technology Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
YoY EBITDA Growth
Get a 7-Day Free Trial 20.16 -45.13 19.86 68.38 22.16

Gwo Xi Stem Cell Applied Technology Co Semi-Annual Data
Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 28.07 113.02 -11.22 -390.00 100.44

Gwo Xi Stem Cell Applied Technology Co YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Gwo Xi Stem Cell Applied Technology Co's YoY EBITDA Growth for the fiscal year that ended in Dec. 2024 is calculated as:

YoY EBITDA Growth (A: Dec. 2024 )
=(EBITDA per Share (A: Dec. 2024 )-EBITDA per Share (A: Dec. 2023 ))/ | EBITDA per Share (A: Dec. 2023 ) |
=(-0.144--0.185)/ | -0.185 |
=22.16 %

Gwo Xi Stem Cell Applied Technology Co's YoY EBITDA Growth for the quarter that ended in Dec. 2024 is calculated as:

YoY EBITDA Growth (Q: Dec. 2024 )
=(EBITDA per Share (Q: Dec. 2024 )-EBITDA per Share (Q: Dec. 2023 )) / | EBITDA per Share (Q: Dec. 2023 )) |
=(0.001--0.228)/ | -0.228 |
=100.44 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Gwo Xi Stem Cell Applied Technology Co YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Gwo Xi Stem Cell Applied Technology Co's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Gwo Xi Stem Cell Applied Technology Co Business Description

Traded in Other Exchanges
N/A
Address
Guangming 6th Road, 8th Floor, No.243, Dong Section 1, Hsinchu County, Zhubei, TWN, 302041
Gwo Xi Stem Cell Applied Technology Co is committed to developing stem cell medicines that have the potential to help patients with unmet medical needs.

Gwo Xi Stem Cell Applied Technology Co Headlines

No Headlines